Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single active application is assigned to a distinct examiner and is being processed in a distinct art unit. This reflects a highly concentrated prosecution profile for the company. The busiest examiner for the portfolio is NOLAN, JASON MICHAEL, who is currently managing 1 busiest examiner pending action.
The fact that there is only 1 pending office action means that a distinct examiner is responsible for the entirety of the company's active workload. The involvement of the distinct art unit further indicates that the technology is situated within a specific technical niche of the Biotechnology & Pharmaceuticals sector. This streamlined arrangement allows the company to focus its response strategy on the specific requirements of NOLAN, JASON MICHAEL, rather than managing multiple examiners across different art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOLAN, JASON MICHAEL | 1 | 66.5% | -27.8% |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18577644 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | NOLAN, JASON MICHAEL | 1617 | §112 | Non-Final OA | — | Pending | Jan 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial